Fujitsu Microelectronics and TSMC to Collaborate on 28-nm Process Technology

Fujitsu Microelectronics Limited and Taiwan Semiconductor Manufacturing Company, Ltd. (TWSE: 2330, NYSE: TSM) today announced that they have agreed to collaborate on 28-nanometer (nm) process technology targeted for foundry production of Fujitsu Microelectronics' 28nm logic ICs and to jointly develop an enhanced 28nm high-performance process technology by utilizing TSMC's advanced technology platform. Previously, both companies announced that Fujitsu Microelectronics will collaborate with TSMC on 40nm production. This will extend Fujitsu Microelectronics' 40nm collaboration with TSMC and covers joint development of an optimized 28nm high-performance process technology. Initial 28nm samples are expected to ship toward the end of 2010.

This collaborative effort combines Fujitsu Microelectronics' expertise and strength in advanced high-speed process and low-power design technologies with TSMC's expertise and strength in power-efficient high- performance logic/SoC process and leading-edge technology platform that is part of the Open Innovation Platform(TM) from TSMC. Extending the collaboration to 28nm will provide the opportunity for both companies to capitalize on a competitive and high-performance 28nm technology based on TSMC's 28nm technology portfolio that includes high-performance and low-power applications.

The two companies are also discussing possibilities for collaborating on advanced packaging that could include joint developments that combine Fujitsu Microelectronics' strengths in high-performance lead-free and ultra-high-pin count packaging technologies, with TSMC's strength in chip-package integration and advanced Cu/ELK interconnect.

"We are rapidly progressing in our previously-announced collaboration with TSMC on 40nm process technology, with several product designs in progress at present," said Haruyoshi Yagi, Corporate Senior Vice President of Fujitsu Microelectronics Limited. "With this further agreement with TSMC on 28nm high-performance process technology development and production, we combine both companies' strengths to create greater value for our customers, and will further drive the growth of businesses for TSMC and Fujitsu's ASIC and ASSP (*1) core products."

"Fujitsu Microelectronics selected TSMC as a partner based in part on TSMC's unsurpassed record of developing and ramping advanced technologies. The agreement today is also a vote of confidence in TSMC's technology platforms that include design related considerations such as design kits, design flows, TSMC and 3rd party IP; robust device related documentation, processes technology excellence and backend assembly and test capabilities," said Jason Chen, Vice President, Worldwide Sales and Marketing, TSMC.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    TSMC Taiwan Semiconductor Manufacturing Company. (2019, March 18). Fujitsu Microelectronics and TSMC to Collaborate on 28-nm Process Technology. AZoNano. Retrieved on November 10, 2024 from https://www.azonano.com/news.aspx?newsID=13343.

  • MLA

    TSMC Taiwan Semiconductor Manufacturing Company. "Fujitsu Microelectronics and TSMC to Collaborate on 28-nm Process Technology". AZoNano. 10 November 2024. <https://www.azonano.com/news.aspx?newsID=13343>.

  • Chicago

    TSMC Taiwan Semiconductor Manufacturing Company. "Fujitsu Microelectronics and TSMC to Collaborate on 28-nm Process Technology". AZoNano. https://www.azonano.com/news.aspx?newsID=13343. (accessed November 10, 2024).

  • Harvard

    TSMC Taiwan Semiconductor Manufacturing Company. 2019. Fujitsu Microelectronics and TSMC to Collaborate on 28-nm Process Technology. AZoNano, viewed 10 November 2024, https://www.azonano.com/news.aspx?newsID=13343.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.